Bloomage Biotechnology Revenue vs. Profit Margin
| 688363 Stock | 57.50 3.32 5.46% |
Total Revenue | First Reported 2019-03-31 | Previous Quarter 1.4 B | Current Value 1.5 B | Quarterly Volatility 534.4 M |
For Bloomage Biotechnology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bloomage Biotechnology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bloomage Biotechnology Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bloomage Biotechnology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bloomage Biotechnology Corp over time as well as its relative position and ranking within its peers.
Bloomage |
Bloomage Biotechnology Profit Margin vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bloomage Biotechnology's current stock value. Our valuation model uses many indicators to compare Bloomage Biotechnology value to that of its competitors to determine the firm's financial worth. Bloomage Biotechnology Corp is the top company in revenue category among its peers. It also is number one stock in profit margin category among its peers . The ratio of Revenue to Profit Margin for Bloomage Biotechnology Corp is about 79,113,591,836 . At present, Bloomage Biotechnology's Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Bloomage Biotechnology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bloomage Biotechnology's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Bloomage Revenue vs. Competition
Bloomage Biotechnology Corp is the top company in revenue category among its peers. Market size based on revenue of Materials industry is presently estimated at about 39.4 Billion. Bloomage Biotechnology retains roughly 6.08 Billion in revenue claiming about 15% of all equities under Materials industry.
Bloomage Profit Margin vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Bloomage Biotechnology |
| = | 6.08 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Bloomage Biotechnology |
| = | 0.08 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Bloomage Profit Margin Comparison
Bloomage Biotechnology is currently under evaluation in profit margin category among its peers.
Bloomage Biotechnology Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bloomage Biotechnology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bloomage Biotechnology will eventually generate negative long term returns. The profitability progress is the general direction of Bloomage Biotechnology's change in net profit over the period of time. It can combine multiple indicators of Bloomage Biotechnology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 1.1 B | 562.4 M | |
| Income Tax Expense | 193.7 M | 106.5 M | |
| Net Interest Income | 26.9 M | 28.2 M | |
| Operating Income | 737.7 M | 730.2 M | |
| Net Income From Continuing Ops | 582.7 M | 613.9 M | |
| Income Before Tax | 701.7 M | 731.1 M | |
| Net Income | 592.6 M | 617.8 M | |
| Interest Income | 38.5 M | 20.6 M | |
| Change To Netincome | 8.8 M | 4.9 M |
Bloomage Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bloomage Biotechnology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bloomage Biotechnology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bloomage Biotechnology's important profitability drivers and their relationship over time.
Use Bloomage Biotechnology in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bloomage Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bloomage Biotechnology will appreciate offsetting losses from the drop in the long position's value.Bloomage Biotechnology Pair Trading
Bloomage Biotechnology Corp Pair Trading Analysis
The ability to find closely correlated positions to Bloomage Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bloomage Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bloomage Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bloomage Biotechnology Corp to buy it.
The correlation of Bloomage Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bloomage Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bloomage Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bloomage Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bloomage Biotechnology position
In addition to having Bloomage Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Blend Funds Thematic Idea Now
Small Blend Funds
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. The Small Blend Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Bloomage Stock
To fully project Bloomage Biotechnology's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bloomage Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bloomage Biotechnology's income statement, its balance sheet, and the statement of cash flows.